COVID-19 vaccine trials should seek worthwhile efficacy – The Lancet Commentary: Covid vaccine rush could make pandemic worse, say scientists – The Guardian   Commentary on Twitter "Although efficacy far greater than 50% would be better, efficacy of about 50% would represent substantial progress" Philip Krause et al for the @WHO Solidarity Vaccines Trial Expert […]

The post Perspective: COVID-19 vaccine trials should seek worthwhile efficacy appeared first on Links Medicus.